CSPAM
ZBH icon

Cary Street Partners Asset Management’s Zimmer Biomet ZBH Stock Holding History

Cary Street Partners Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$886K Buy
8,207
+958
+13% +$105K 0.12% 122
2024
Q2 		$787K Hold
7,249
– – 0.12% 125
2024
Q1 		$957K Buy
7,249
+214
+3% +$26.7K 0.15% 111
2023
Q4 		$856K Sell
7,035
-255
-3% -$28.5K 0.15% 111
2023
Q3 		$818K Buy
7,290
+958
+15% +$122K 0.15% 112
2023
Q2 		$922K Sell
6,332
-55
-0.9% -$7.47K 0.17% 106
2023
Q1 		$825K Sell
6,387
-490
-7% -$61.5K 0.16% 106
2022
Q4 		$877K Sell
6,877
-485
-7% -$56.3K 0.18% 108
2022
Q3 		$770K Buy
7,362
+625
+9% +$68.6K 0.18% 101
2022
Q2 		$708K Sell
6,737
-105
-2% -$12.5K 0.17% 105
2022
Q1 		$875K Sell
6,842
-267
-4% -$32.2K 0.17% 110
2021
Q4 		$877K Buy
7,109
+1,058
+17% +$138K 0.19% 114
2021
Q3 		$860K Sell
6,051
-189
-3% -$27.8K 0.3% 90
2021
Q2 		$975K Sell
6,240
-69,330
-92% -$11.2M 0.23% 96
2021
Q1 		$981K Buy
75,570
+6,539
+9% +$1.01M 0.24% 94
2020
Q4 		$891K Buy
+69,031
New +$9.75M 0.26% 86

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Cary Street Partners Asset Management's ZBH Position: Q3 2024 in Review

Cary Street Partners Asset Management increased its Zimmer Biomet (ZBH) stake by 13% in Q3 2024, buying an estimated $105K and bringing the position to 8,207 shares worth $886K. The position accounts for 0.12% of the portfolio, ranked #122.

Cary Street Partners Asset Management first reported a position in ZBH in Q4 2020 and has held it in 16 quarters since. The position peaked at $981K in Q1 2021. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • Cary Street Partners Asset Management held 8,207 shares of Zimmer Biomet worth $886K as of Q3 2024.
  • Cary Street Partners Asset Management bought 958 Zimmer Biomet shares in Q3 2024, an estimated $105K.
  • Zimmer Biomet made up 0.12% of Cary Street Partners Asset Management's portfolio in Q3 2024, its #122 holding.
  • Cary Street Partners Asset Management first reported a position in Zimmer Biomet in Q4 2020 and has held it in 16 quarters since.
  • Cary Street Partners Asset Management's Zimmer Biomet position peaked at $981K in Q1 2021.
  • 982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Cary Street Partners Asset Management's 13F filing for Q3 2024, filed 30 Oct 2024.